ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 190

A Meta-Analysis and  Systematic Literature Review: Effect Of The Method Used To Measure Adherence In Rheumatoid Arthritis On Its Rate, and Evaluation Of Associated Factors

Anat Scheiman-Elazary1, Cortney Shourt2, M. Cameron Hay3 and Daniel Furst4, 1Rheumatology, Rheumatology UCLA, Los Angeles, CA, 2Rheumatology UCLA, Los Angeles, CA, 3Anthropology Miami University, Oxford, OH, 4Rheumatology, David Geffen School of Medicine, UCLA, Los Angeles, CA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Health Services Research, Quality Measures and Quality of Care-Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Adherence reported in the literature for RA varies widely (49.5-98%)1. This variability may result in part from different methods used to measure adherence. Our aim was to examine whether adherence is influenced by the method used to measure it through a meta-analysis. We also conducted a systematic literature review (SLR) on factors that are associated with adherence.

Methods:

Systematic literature review was conducted using PubMed and Cochrane central database as well as associated reference lists from reviews from 1970 to Nov. 2012. Papers were included if they  reported DMARD adherence  data or factors associated with adherence in adult RA patients and if adherence was defined. Aspirin/NSAID or non pharmaceutical therapy were excluded. Papers were divided according to the method used to measure adherence. A Random effects model estimated adherence and a Binomial significance test was used to identify significant factors associated with adherence.

Results:

Out of an initial 273 articles, 26 papers were included, including 34,700 RA patients. Figure 1 details the results of the meta-analysis for adherence, showing  2-8 articles for each method. Adherence rates were statistically  similar when measured by interview, questionnaires, pill count, drug level or medication effect monitoring system (MEMS), although there was an 11% mean numerical range. There was a numerically but not statistically lower adherence when measured by prescription claims  (0.59 for prescription claims versus 0.72-0.83 for the other  methods).

Associated factors- Three factors were associated with increased  adherence. 1.Patients belief about the necessity of medications and the ability to control pain, disease activity or negative mood related to arthritis. 2. Use of  Infliximab compared to either Etanercept, Methotrexate or Anakinra. 3. Use of  DMARDs prior to anti TNF therapy.  Two factors were associated with decreased adherence, use of  Sulfasalazine compared to Methotrexate and use of Anakinra compared to Etanercept. Limitations- there were few articles using any one method and quality was variable, resulting in increased variability and decreased ability to separate the methods.

Conclusion:

There was a numerical tendency for decreased rate of adherence when measured by prescription claims versus the other methods. Patient beliefs and  specific  DMARDs  are associated with adherence.

Ref.

1. Pasma A et al. Semin Arthritis Rheum, 2013.

 


Disclosure:

A. Scheiman-Elazary,
None;

C. Shourt,
None;

M. C. Hay,
None;

D. Furst,

AbbVie,

2,

Actelion Pharmaceuticals US,

2,

Amgen,

2,

BMS,

2,

Gilead,

2,

GSK,

2,

NIH,

2,

Novartis Pharmaceutical Corporation,

2,

Pfizer Inc,

2,

Roche/Genentech,

2,

UCB,

2,

Janssen Pharmaceutica Product, L.P.,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-meta-analysis-and-systematic-literature-review-effect-of-the-method-used-to-measure-adherence-in-rheumatoid-arthritis-on-its-rate-and-evaluation-of-associated-factors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology